合并后的实体将作为Akari Therapeutics, Plc运营,预计将继续在纳斯达克资本市场上市并以AKTX的名称交易。
$海正药业(SH600267)$查看全文
Akari Therapeutics(AKTX)03-05 21:55
$Akari Therapeutics(AKTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-24-030781 Act: 34 Size: 5 MB 网页链接查看全文
Akari Therapeutics(AKTX)03-30 04:25
$Akari Therapeutics(AKTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038661 Act: 34 Size: 9 MB 网页链接查看全文
Akari Therapeutics(AKTX)04-01 18:35
$Akari Therapeutics(AKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038854 Act: 34 Size: 365 KB 网页链接查看全文
Akari Therapeutics(AKTX)03-05 21:35
$Akari Therapeutics(AKTX)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001104659-24-030777 Act: 34 Size: 6 MB 网页链接查看全文
Akari Therapeutics(AKTX)05-08 05:15
$Akari Therapeutics(AKTX)$ 8-K Current report, items 2.05 and 5.02 Accession Number: 0000950170-24-054726 Act: 34 Size: 279 KB 网页链接查看全文
Akari Therapeutics(AKTX)05-04 04:55
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-053000 Size: 5 KB 网页链接查看全文
Akari Therapeutics(AKTX)03-12 05:35
$Akari Therapeutics(AKTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-24-033088 Act: 34 Size: 254 KB 网页链接查看全文
Akari Therapeutics(AKTX)05-01 09:55
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-050854 Size: 5 KB 网页链接查看全文
$Akari Therapeutics(AKTX)$ 8-K Current report, items 2.05 and 5.02 Accession Number: 0000950170-24-054726 Act: 34 Size: 279 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-053000 Size: 5 KB 网页链接
$Akari Therapeutics(AKTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0000950170-24-051410 Act: 34 Size: 111 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0000950170-24-051383 Act: 34 Size: 359 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-050854 Size: 5 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, item 3.01 Accession Number: 0000950170-24-043519 Act: 34 Size: 264 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038854 Act: 34 Size: 365 KB 网页链接
$Akari Therapeutics(AKTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038661 Act: 34 Size: 9 MB 网页链接
$Akari Therapeutics(AKTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-24-033088 Act: 34 Size: 254 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001104659-24-033087 Act: 34 Size: 535 KB 网页链接